Brad-Chem Holdings Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 11028075 (England and Wales)

Unaudited Financial Statements

for the Period 1 October 2023 to 31 December 2024

for

Brad-Chem Holdings Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

P G Bryant

Ms I Trainar

SECRETARY:

REGISTERED OFFICE:

Aquarius House

6 Mid Point Business Park

Thornbury

Bradford

BD3 7AY

REGISTERED NUMBER:

11028075 (England and Wales)

ACCOUNTANTS:

Robbins

176 Monton Road

Monton

Greater Manchester

M30 9GA

FIXED ASSETS

Investments

4

3,130,853

CURRENT ASSETS

Debtors

5

93,373

-

CREDITORS

Amounts falling due within one year

6

828,193

731,118

NET CURRENT LIABILITIES

(734,820

)

(731,118

)

TOTAL ASSETS LESS CURRENT
LIABILITIES

2,396,033

2,399,735

CREDITORS

Amounts falling due after more than one
year

7

645,000

NET ASSETS

1,751,033

1,754,735

CAPITAL AND RESERVES

Called up share capital

100

Merger reserve

1,294,637

Capital redemption reserve

455,000

Retained earnings

1,296

4,998

SHAREHOLDERS' FUNDS

1,751,033

1,754,735

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 September 2025 and were signed on its behalf by:

P G Bryant - Director

1.	STATUTORY INFORMATION

Brad-Chem Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements

The financial statements contain information about Brad-Chem Holdings Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Prior year adjustment

The financial statements for the year ended 30 September 2023 have been revised.

They

- replace the original financial statements

- are now the statutory financial statements

- are prepared as they were at the date of the original financial statements and not as at the date of the revision and accordingly do not deal with the events between those dates.

The original accounts did not include all dividends received, some were mistakenly treated as a loan.

Correct disclosure has now been made and there is no impact on corporation tax.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2023 - NIL).

4.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 October 2023

and 31 December 2024

3,130,853

NET BOOK VALUE

At 31 December 2024

3,130,853

At 30 September 2023

3,130,853

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

30.9.23

as restated

£

Other debtors

93,373

-

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

30.9.23

as restated

£

Amounts owed to group undertakings

820,192

32,915

Other creditors

8,001

698,203

828,193

731,118

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

31.12.24

30.9.23

as restated

£

Other creditors

645,000

8.	SECURED DEBTS

The following secured debts are included within creditors:

31.12.24

30.9.23

as restated

£

Loan Notes

-

200,000

Included in creditors in prior years were secured loan notes due to Mrs A F Brady.

With effect from 22 November 2017 there was a Fixed charge over all estates or interests in any freehold or leasehold property belonging to the company now or at any time after the date of the debenture, Fixed charge over all patents, patent applications, trade marks and trade mark applications.

The charge contained a floating charge covering all the property or undertaking of the company and contained a negative pledge.

The above charge was satisfied on 30 January 2025.

9.	FINANCIAL INSTRUMENTS

Included in creditors over one year are redeemable preference shares.

The company may at any time after 12 months following the adoption date give written notice to redeem all or any part of the preference shares on a date to be determined by the Board.

10.	RELATED PARTY DISCLOSURES

Included in Other debtors is an amount due from the director, Mr C E Brady of £93,373. This was repaid on 1 February 2025.

11.	ULTIMATE CONTROLLING PARTY

On the balance sheet date the Company was ultimately controlled by the Trustees of The Christopher Edward Brady Trust.

On 4 February 2025, the shares of Brad-Chem Holdings Limited were sold to Univar Solutions UK Holdco Limited (a company registered in England and Wales). The Company's ultimate parent company is Windsor Holdings One, Inc., a company incorporated in Delaware, USA, whilst the Company's ultimate controlling party is an affiliate of funds managed by affiliates of Apollo Global Management, Inc.